CSR Program: Jhpiego | Takeda Pharmaceuticals
Raising the quality and continuity of care and leveraging predictive analytics and innovative financing in maternal and newborn health
India accounts for 17% of global maternal deaths and 26% of global neonatal deaths. Delays in reaching and receiving care, inadequate provider competency, poor care quality, limited data availability and fragmented systemic support contribute to adverse effects for women and newborns. The program will decentralize care to promote coordinated, patient-centered approaches for antenatal through to postnatal care; develop a digital tracking platform for pregnant women; and enable early identification of high-risk pregnancies by leveraging predictive analytics. The program aims to provide targeted care to women and encourage informed decision-making.
Photo Credit: Indrani Kashyap
Photo Credit: Kanika Bajaj
Photo Credit: Kate Holt
Banner Image Credit: Indrani Kashyap